FDA NDC Directory · JSON-LD · Markdown

Cyclobenzaprine Hydrochloride

NDC 76420-896 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerAsclemed USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091281
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsCYCLOBENZAPRINE HYDROCHLORIDE (30 mg/1)
Marketing started20190301
Package count4

External sources

Source: openFDA. Public-domain (CC0).